Showing results (41-50 of 88) with videos related to
Sort By:
Pageof 9
Leukemia Research|August 25, 2019
Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failureJan Stratmann, Elisabeth van Kann, Christoph Rummelt, et al.American Journal of Hematology|April 28, 2009
Elevated AF1q expression is a poor prognostic marker for adult acute myeloid leukemia patients with normal cytogeneticsCrawford J Strunk, Uwe Platzbecker, Christian Thiede, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2009
Prognostic factors in adult patients up to 60 years old with acute myeloid leukemia and translocations of chromosome band 11q23: individual patient data-based meta-analysis of the German Acute Myeloid Leukemia IntergroupJürgen Krauter, Katharina Wagner, Irina Schäfer, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 26, 2009
Expression of ABCC-type nucleotide exporters in blasts of adult acute myeloid leukemia: relation to long-term survivalYanping Guo, Kathleen Köck, Christoph A Ritter, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2011
Long-term prognosis of acute myeloid leukemia according to the new genetic risk classification of the European LeukemiaNet recommendations: evaluation of the proposed reporting systemChristoph Röllig, Martin Bornhäuser, Christian Thiede, et al.Transplantation|February 9, 2012
Clonal evolution including partial loss of human leukocyte antigen genes favoring extramedullary acute myeloid leukemia relapse after matched related allogeneic hematopoietic stem cell transplantationFriedrich Stölzel, Karl Hackmann, Friederike Kuithan, et al.Haematologica|November 3, 2009
Monitoring of donor chimerism in sorted CD34+ peripheral blood cells allows the sensitive detection of imminent relapse after allogeneic stem cell transplantationMartin Bornhäuser, Uta Oelschlaegel, Uwe Platzbecker, et al.Haematologica|August 31, 2019
The prevalence of extramedullary acute myeloid leukemia detected by <sup>18</sup>FDG-PET/CT: final results from the prospective PETAML trialFriedrich Stölzel, Tors Lüer, Steffen Löck, et al.Blood|May 6, 2010
A novel prognostic model in elderly patients with acute myeloid leukemia: results of 909 patients entered into the prospective AML96 trialChristoph Röllig, Christian Thiede, Martin Gramatzki, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 25, 2011
Cytarabine dose of 36 g/m² compared with 12 g/m² within first consolidation in acute myeloid leukemia: results of patients enrolled onto the prospective randomized AML96 studyMarkus Schaich, Christoph Röllig, Silke Soucek, et al.Pageof 9